More information: Abstract no: 12, "On-target mutations drive resistance to WRN helicase inhibitors in microsatellite ...
Although pembrolizumab is approved for deficient mismatch repair or microsatellite instability-high (dMMR/MSI-H) tumors regardless of histology, there is a paucity of data to support its effectiveness ...
The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...
Professor Yoon Jong-hyuk (Gastrointestinal Surgery) of Cheonan Hospital, affiliated with Soonchunhyang University, recently won the Excellence Researcher Awar ...
(ends) Abstract no: 12, “On-target mutations drive resistance to WRN helicase inhibitors in microsatellite unstable colorectal cancer”, by Gabriele Picco, presented in plenary session 7 ...